The British Health Secretary Matt Hancock has called a review to end "polypharmacy." As during a survey it was found that nearly half of those over 75-year-olds were taking five or more medicines.
The review will look at patients most at risk of suffering from adverse effects from overprescribing of tablets and pills, Xinhua news agency reported.
Spending on medicines by the National Health Service (NHS) in England has grown from $16.55 billion in 2010-2011 to over $23 billion in 2017-2018, an average growth of around 5 percent .
Chief Pharmaceutical Officer Dr. Keith Ridge will lead the review into medicine use. He will look at addressing "problematic polypharmacy" where patients take multiple medicines unnecessarily, the report said.
Ridge said recent successes by NHS England to reduce unnecessary antibiotics and medicines in care homes and family doctor surgeries, known as polypharmacy, are beginning to end overmedication for people with learning disabilities, showing what can be done on what is an important topic.
The review will consider individual circumstances where patients may be most at risk of suffering from adverse effects from overprescribing.
The overprescribing of medicines can be dangerous for older people who often take a cocktail of different medicines to manage complex health conditions, said health officials.
They may suffer side effects of their medicine regimes that lead to them falling and being admitted to hospital. Some patients remain for years on repeat prescriptions which roll over without ever being reviewed by doctors.
The British Health Secretary said: "Poorly managed prescribing can lead to serious issues for patients such as increased admissions to hospital or antibiotic resistance.
"As we invest an extra 20.5 billion pounds ($26.1 billion) a year into our NHS we want to empower doctors and pharmacists to use the data available to ensure patients get the medicines they need and stop taking those that no longer benefit them."
The survey will also look at the role of digital technologies in reducing overprescribing as well as increasing other forms of care, including social prescribing.